Singular Genomics Systems Inc expected to post a loss of 41 cents a share - Earnings Preview

Singular Genomics Systems

05/11/2022 24:53

* Singular Genomics Systems Inc  OMIC.OQ   OMIC.O  is
expected
to show a rise in quarterly revenue when it reports  results on
November 7. 
    * The San Diego California-based  company is expected to
report
revenue of $75 thousand, according to the mean estimate from 4
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Singular Genomics
Systems
Inc is for a loss of 41 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Singular
Genomics
Systems Inc is $3.5​, above​ its last closing price of $2.30.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.39       -0.38      -0.34     Beat    11.5
 Mar. 31 2022  -0.33       -0.33      -0.31     Beat    7
 Dec. 31 2021  -0.31       -0.31      -0.27     Beat    12.3​
 Sep. 30 2021  -0.24       -0.24      -0.25     Missed  -4.2
 ​​Jun.        -0.20       -0.20      -0.43     Missed  -111.5
 30 2021                                                
                                                        ​
 This summary was machine generated November 5 at 00:53 GMT.  All
figures in US dollars  unless otherwise stated